Epigallocatechin-3-Gallate attenuates lipopolysacharide-induced pneumonia via modification of inflammation, oxidative stress, apoptosis, and autophagy
Article in BMC Complementary Medicine and Therapies (April 2024)
The most recent citing publications are shown below. View all 86 publications that cite this research output on Dimensions.
Article in BMC Complementary Medicine and Therapies (April 2024)
Article in Biogerontology (January 2024)
Article in Current Molecular Pharmacology (January 2024)